Saliva swabs could replace blood draws for monitoring IBD treatment
NCT ID NCT07470502
First seen Mar 17, 2026 · Last updated Apr 29, 2026 · Updated 7 times
Summary
This study looks at whether measuring infliximab (a drug for inflammatory bowel disease) in saliva is as good as measuring it in blood. Fifteen children starting infliximab will provide saliva and leftover blood samples during routine visits. The goal is to see if saliva can be used for monitoring, but this is just an early exploration and won't change treatment yet.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBD-INFLAMMATORY BOWEL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Meyer Children's Hospital, IRCCS - Gastroenterology and Nutrition Unit
RECRUITINGFlorence, Italy, 50139, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.